NPL: Barrier, Animal Source, Intraoral
What it covers
An animal source dental barrier is an animal-derived material device, such as collagen, intended to aid in guided tissue/bone regeneration procedures and to act as a stable barrier for the containment of bone graft materials when placed around implants.
FDA’s definition of product code NPL, from the Product Classification database.
FDA flags NPL devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K242817 | Jason membrane | Botiss Biomaterials GmbH | Dec 12, 2025 | Traditional |
| K250512 | Augmented Gingival Matrix | Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd. | Dec 5, 2025 | Traditional |
| K252253 | Geistlich Mucograft® /Geistlich Mucograft® Seal; Geistlich Fibro-Gide® | Geistlich Pharma AG | Nov 25, 2025 | Traditional |
| K251062 | Geistlich Bio-Gide; Geistlich Bio-Gide® Shape; Geistlich Bio-Gide® Compressed; Geistlich Bio-Gide® Forte; Geistlich Bio-Gide® Perio; Geistlich Combi-Kit Collagen®; Geistlich Perio-System Combi Pack | Geistlich Pharma AG | Aug 14, 2025 | Traditional |
| K250833 | SwissMembrane X; SwissMembrane X Socket | Geistlich Pharma AG | Apr 15, 2025 | Special |
| K233203 | Soft Tissue Augmentation Resorbable Matrix | Collagen Matrix, Inc. | May 1, 2024 | Traditional |
| K231513 | Oral Matrix | Beijing Biosis Healing Biolog Ical Technology Co., Ltd. | Feb 16, 2024 | Traditional |
| K231305 | Endoform Dental Membrane | Aroa Biosurgery , Ltd. | Jan 23, 2024 | Traditional |
| K230091 | THE Cover | Purgo Biologics, Inc. | Oct 6, 2023 | Traditional |
| K223912 | InterCollagen® Guide | Sigmagraft, Inc. | Aug 17, 2023 | Traditional |
Clearances by year
37 NPL 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2025 | 5 | 132 |
| 2024 | 3 | 263 |
| 2023 | 2 | 249 |
| 2022 | 3 | 290 |
| 2021 | 2 | 139 |
| 2020 | 2 | 314 |
| 2019 | 1 | 29 |
| 2018 | 1 | 234 |
| 2017 | 3 | 200 |
| 2016 | 3 | 184 |
| 2015 | 1 | 496 |
| 2014 | 5 | 140 |
| 2013 | 2 | 733 |
| 2011 | 4 | 286 |
Who submits
24 applicants cleared a NPL device since 2011. 35% of the clearances went to applicants in United States, then Switzerland (24%), Israel (8%) and China (5%). By type: Traditional 89% and Special 11%.
| Applicant | Clearances since 2011 |
|---|---|
| Geistlich Pharma AG | 9 |
| Collagen Matrix, Inc. | 4 |
| Datum Dental, Ltd. | 3 |
| Aroa Biosurgery , Ltd. | 1 |
| Beijing Biosis Healing Biolog Ical Technology Co., Ltd. | 1 |
| Biom'Up Sas | 1 |
| Botiss Biomaterials GmbH | 1 |
| Collamatrix, Inc. | 1 |
How FDA classifies it
(1) Class II (special controls) for bone grafting materials that do not contain a drug that is a therapeutic biologic. The special control is FDA's “Class II Special Controls Guidance Document: Dental Bone Grafting Material Devices.” (See § 872.1(e) for the availability of this guidance document.)
(2) Class III (premarket approval) for bone grafting materials that contain a drug that is a therapeutic biologic. Bone grafting materials that contain a drug that is a therapeutic biologic, such as biological response modifiers, require premarket approval.
From 21 CFR 872.3930. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 872.3930 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NPL clearances declared.
Ask about NPL
Questions about NPL
What is FDA product code NPL?
Product code NPL, “Barrier, Animal Source, Intraoral” in FDA's classification database, is a Class II device type under 21 CFR 872.3930 (bone grafting material), reviewed by FDA's Dental panel. FDA's 510(k) database lists 57 clearances under NPL, 37 of them since 2011.
How many 510(k) clearances are there under NPL?
FDA’s 510(k) database listed 57 clearances under NPL as of Oct 29, 2026, 37 of them decided since 2011; the most recent decision was Dec 12, 2025. The Predicate Finder searches the live database.
How long does FDA take to clear a NPL 510(k)?
For the 5 NPL clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 132 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most NPL clearances?
Since 2011: Geistlich Pharma AG (9), Collagen Matrix, Inc. (4), Datum Dental, Ltd. (3), Aroa Biosurgery , Ltd. (1) and Beijing Biosis Healing Biolog Ical Technology Co., Ltd. (1). 24 applicants have cleared a NPL device in that time.